KEY FINDINGS In an eight-week randomized, double-blind, placebo-controlled trial involving 50 adults seeking treatment for moderate-to-severe AUD, participants receiving oral semaglutide showed: Fewer heavy drinking days Reduced alcohol consumption per drinking occasion Lower day-to-day alcohol cravings Fewer alcohol-related problems Improved overall drinking risk level Reduced cannabis use days While not all measures changed in controlled laboratory settings, the overall pattern showed consistent reductions in harmful real-world drinking behavior
At Pine Point Medical, we offer medically supervised GLP-1 weight loss treatments including Semaglutide (Ozempic, Wegovy, Rybelsus) and Tirzepatide (Mounjaro, Zepbound)
When purchasing prescription weight loss medication online, safety and authenticity are paramount
The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation
Some prefer bi-weekly treatments during high-stress periods, while others find quarterly sessions sufficient for seasonal support